当前位置: 首页 > 期刊 > 《健康必读》 > 2013年第11期
编号:13149049
进展期胃癌术后DC疫苗同步化疗的临床疗效观察(2)
http://www.100md.com 2013年11月1日 《健康必读》 2013年第11期
     总之,DC疫苗联合化疗治疗胃癌是一种可供临床选择的新方法,值得有条件的医疗机构推广应用?

    参考文献

    [1] 许炳华,吕国强,沈晓明等.自体胃癌细胞致敏的DC疫苗对胃癌术后免疫功能的影响[J].江苏医药,2008,34(12):1253-1255.

    [2] 邵纯,宋洁,徐志萍.DC疫苗埋藏式多点皮内注射在肿瘤免疫治疗中的应用及临床观察[J].护士进修杂志,2008,23(7):649-650.

    [3] DEPAN C, RILEY JP. Hybrids of dendritic cells and tumor cells generated by electrofusionsimultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules[J]. J Immunol, 2003,170 (10): 5317-5325.

    [4 ] VASIR B, BORGES V, WU Z, et al. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation[J]. Br J Haematol, 2005, 129(5): 687-700.

    [5] 钟华,韩宝惠. 低剂量安素联合树突状细胞治疗小鼠肺癌的疗效研究[J]. 临床肿瘤学杂志,2007, 12(5): 332-338.

    [6] WEIHRAUCH MR, ANSEN S, JURKIEWICZ E, Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorirracil, and leucovri in patients with primary metastatic colorectal cancer[J]. Clin Cancer Res, 2005, 11(16):5993-6001., http://www.100md.com(唐世彩)
上一页1 2